Asset Dedication, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Asset Dedication, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7
-12.5%
2680.0%0.00%0.0%
Q2 2023$80.0%2680.0%0.00%0.0%
Q1 2023$8
-27.3%
2680.0%0.00%0.0%
Q4 2022$11
-99.9%
2680.0%0.00%0.0%
Q3 2022$13,000
+18.2%
2680.0%0.00%
-50.0%
Q2 2022$11,000
-26.7%
2680.0%0.00%0.0%
Q1 2022$15,000
-6.2%
268
+34.0%
0.00%0.0%
Q4 2021$16,000
-5.9%
2000.0%0.00%0.0%
Q3 2021$17,0002000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders